BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 17204094)

  • 1. Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease.
    Dilling A; Rose C; Hashimoto T; Zillikens D; Shimanovich I
    J Dermatol; 2007 Jan; 34(1):1-8. PubMed ID: 17204094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-p200 pemphigoid--a new bullous autoimmune dermatosis].
    Shimanovich I; Rose C; Hirako Y; Butt-Dörje E; Zillikens D
    J Dtsch Dermatol Ges; 2004 Jan; 2(1):7-14. PubMed ID: 16281877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathology of anti-p200 pemphigoid.
    Rose C; Weyers W; Denisjuk N; Hillen U; Zillikens D; Shimanovich I
    Am J Dermatopathol; 2007 Apr; 29(2):119-24. PubMed ID: 17414431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.
    Meijer JM; Diercks GF; Schmidt E; Pas HH; Jonkman MF
    JAMA Dermatol; 2016 Aug; 152(8):897-904. PubMed ID: 27167149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-p200 pemphigoid.
    Goletz S; Hashimoto T; Zillikens D; Schmidt E
    J Am Acad Dermatol; 2014 Jul; 71(1):185-91. PubMed ID: 24767733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subepidermal blistering disease with autoantibodies to both the p200 autoantigen and the alpha3 chain of laminin 5.
    Shimanovich I; Petersen EE; Weyers W; Sitaru C; Zillikens D
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S90-2. PubMed ID: 15858518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgA anti-p200 pemphigoid.
    Wozniak K; Hashimoto T; Fukuda S; Ohyama B; Ishii N; Koga H; Dainichi T; Kowalewski C
    Arch Dermatol; 2011 Nov; 147(11):1306-10. PubMed ID: 22106117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
    Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
    J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid.
    Kasperkiewicz M; Hoppe U; Zillikens D; Schmidt E
    Clin Exp Dermatol; 2010 Aug; 35(6):614-7. PubMed ID: 19874345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid.
    Dainichi T; Koga H; Tsuji T; Ishii N; Ohyama B; Ueda A; Natsuaki Y; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):231-8. PubMed ID: 20507386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orf-induced immunobullous disease: A distinct autoimmune blistering disorder.
    White KP; Zedek DC; White WL; Simpson EL; Hester E; Morrison L; Lazarova Z; Liu D; Scagliarini A; Kurtz SE; White CR; Yancey KB; Blauvelt A
    J Am Acad Dermatol; 2008 Jan; 58(1):49-55. PubMed ID: 17919774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The autoantigen of anti-p200 pemphigoid is an acidic noncollagenous N-linked glycoprotein of the cutaneous basement membrane.
    Shimanovich I; Hirako Y; Sitaru C; Hashimoto T; Bröcker EB; Butt E; Zillikens D
    J Invest Dermatol; 2003 Dec; 121(6):1402-8. PubMed ID: 14675190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of Brunsting-Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa.
    Minato H; Ishii N; Fukuda S; Wakasa T; Wakasa K; Sogame R; Hashimoto T; Horiguchi Y
    J Dermatol; 2011 Sep; 38(9):887-92. PubMed ID: 21366683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of a Simple Immunohistochemical Staining Technique to Differentiate Anti-p200 Pemphigoid From Other Autoimmune Blistering Diseases: A Report of 2 Cases.
    García-Díez I; Martínez-Escala ME; Ishii N; Hashimoto T; Mascaró Galy JM; Pujol RM; Herrero-González JE
    Actas Dermosifiliogr; 2017; 108(1):e1-e5. PubMed ID: 27095685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid.
    Groth S; Recke A; Vafia K; Ludwig RJ; Hashimoto T; Zillikens D; Schmidt E
    Br J Dermatol; 2011 Jan; 164(1):76-82. PubMed ID: 20854435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Korean case of anti-p200 pemphigoid.
    Cho SB; Kim SC
    Yonsei Med J; 2003 Oct; 44(5):931-4. PubMed ID: 14584115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of psoriasis and an unusual IgG-mediated subepidermal bullous dermatosis: identification of a novel 200-kDa lower lamina lucida target antigen.
    Chen KR; Shimizu S; Miyakawa S; Ishiko A; Shimizu H; Hashimoto T
    Br J Dermatol; 1996 Feb; 134(2):340-6. PubMed ID: 8746353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
    Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-p200 pemphigoid].
    Holtsche MM; Goletz S; Zillikens D
    Hautarzt; 2019 Apr; 70(4):271-276. PubMed ID: 30868255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.